Evidence map›Paper›PMID 42192298›Full record

ArticleBMC plant biology2026

A hybrid SE-ResNet50 deep learning framework for high-accuracy and explainable cotton leaf disease classification.

Emrah Aslan, Yıldırım Özüpak

Abstract read
In one paragraph

Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emrah AslanFaculty of Engineering and Architecture, Mardin Artuklu University, Mardin, Turkey.ORCID http://orcid.org/0000-0002-0181-3658
Yıldırım ÖzüpakSilvan Vocational School, Dicle University, Diyarbakır, Turkey. yildirim.ozupak@dicle.edu.tr.ORCID http://orcid.org/0000-0001-8461-8702

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cotton production is highly vulnerable to foliar diseases and pest-induced damage, which significantly reduce yield and compromise fiber quality. Rapid, reliable, and automated disease identification is therefore essential for supporting sustainable crop management. In this study, we propose a hybrid deep learning framework integrating a ResNet50 backbone with Squeeze-and-Excitation (SE) channel attention modules to enhance discriminative feature representation for cotton leaf disease classification. The model is trained on a publicly available disease dataset comprising six classes and optimized using Weighted CrossEntropyLoss, Adam optimization, ReduceLROnPlateau scheduling, and Early Stopping to ensure stable convergence and robust generalization. Experimental results demonstrate outstanding performance, achieving 99.72% training accuracy and 99.31% validation accuracy, with convergence at the 14th epoch. Visualization through Grad-CAM reveals that the model focuses on biologically relevant symptom regions, thereby enhancing interpretability and supporting expert validation. Comparative analysis with state-of-the-art methods shows that the proposed model surpasses existing CNN, transfer learning, and hybrid architectures in both accuracy and model transparency. These results indicate that the proposed SE-ResNet50 framework offers a highly accurate, interpretable, and computationally efficient solution suitable for real-world cotton disease monitoring and precision agriculture applications.Clinical trial registrationThis study is not a clinical trial; therefore, clinical trial registration is not applicable.

Indexed as

Deep LearningGossypiumPlant DiseasesPlant LeavesConvolutional Neural NetworksCotton Disease DetectionDeep LearningExplainable AISE-ResNet50

Identifiers

PMID42192298
PMCPMC13393842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.